Anti-Siglec-2 / CD22 Reference Antibody (inotuzumab-MMAE), expressed in CHO cells, comprises a huIgG1 heavy chain and a hukappa light chain. The predicted molecular weight (MW) of this antibody is 146.48 kDa.
Target:
Immunology/Inflammation related
* VAT and and shipping costs not included. Errors and price changes excepted